OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ORCAY$4.8155

Orcay Ortakoy Cay Sanayi ve Ticaret AS

Food ProcessingVerified

Orcay Ortakoy has a market capitalization of 1.15 billion TRY and a price-to-book ratio of 2.98, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 1.96, suggesting it can cover its short-term liabilities with its current assets. However, the company's cash and equivalents amount to only 3.95 million TRY, which is significantly lower than its long-term debt of 234.66 million TRY, resulting in a negative net cash position. Profitability metrics show a challenging performance, with a return on equity (ROE) of -6.47% and a return on assets (ROA) of -3.55%, both below the industry median for food processing firms. The company reported a net loss of 25.11 million TRY, despite generating an operating income of 45.05 million TRY, indicating inefficiencies in managing non-operating expenses. Gross profit of 54.64 million TRY on revenue of 259.72 million TRY suggests a gross margin of approximately 21%, which is in line with the industry average. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and supply chain disruptions. The company's operating cash flow of 133.25 million TRY is positive, but its free cash flow is negative at -27.69 million TRY, primarily due to capital expenditures of 8.19 million TRY. Looking ahead, the company's revenue outlook is uncertain, with no clear direction provided in the available data. The operating cash flow remains a key indicator to monitor for signs of improving financial health. The company's debt-to-equity ratio of 0.6 suggests a moderate level of leverage, but the negative net cash position raises concerns about its ability to meet long-term obligations. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's key financial flag is the negative net cash position after subtracting total debt, which could impact its ability to fund operations and investments. No recent filings or transcripts have been disclosed that provide additional insight into the company's strategic direction or operational performance.

30-day price · ORCAY+1.48 (+45.7%)
Low$3.20High$5.29Close$4.72As of15 May, 00:00 UTC
Profile
CompanyOrcay Ortakoy Cay Sanayi ve Ticaret AS
TickerORCAY.IS
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. Orcay Ortakoy Cay Sanayi ve Ticaret AS operates in the food processing industry, manufacturing and distributing food products, primarily within the consumer non-cyclicals sector.

Classification. The company is classified under the Food Processing industry within the Food & Beverages business sector, with a high confidence level of 0.92.

Orcay Ortakoy has a market capitalization of 1.15 billion TRY and a price-to-book ratio of 2.98, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 1.96, suggesting it can cover its short-term liabilities with its current assets. However, the company's cash and equivalents amount to only 3.95 million TRY, which is significantly lower than its long-term debt of 234.66 million TRY, resulting in a negative net cash position. Profitability metrics show a challenging performance, with a return on equity (ROE) of -6.47% and a return on assets (ROA) of -3.55%, both below the industry median for food processing firms. The company reported a net loss of 25.11 million TRY, despite generating an operating income of 45.05 million TRY, indicating inefficiencies in managing non-operating expenses. Gross profit of 54.64 million TRY on revenue of 259.72 million TRY suggests a gross margin of approximately 21%, which is in line with the industry average. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and supply chain disruptions. The company's operating cash flow of 133.25 million TRY is positive, but its free cash flow is negative at -27.69 million TRY, primarily due to capital expenditures of 8.19 million TRY. Looking ahead, the company's revenue outlook is uncertain, with no clear direction provided in the available data. The operating cash flow remains a key indicator to monitor for signs of improving financial health. The company's debt-to-equity ratio of 0.6 suggests a moderate level of leverage, but the negative net cash position raises concerns about its ability to meet long-term obligations. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's key financial flag is the negative net cash position after subtracting total debt, which could impact its ability to fund operations and investments. No recent filings or transcripts have been disclosed that provide additional insight into the company's strategic direction or operational performance.
Key takeaways
  • Orcay Ortakoy is valued at a premium to book, with a price-to-book ratio of 2.98.
  • The company is unprofitable, with a negative ROE of -6.47% and a net loss of 25.11 million TRY.
  • Liquidity is moderate, with a current ratio of 1.96, but the company has a negative net cash position.
  • The company's revenue is concentrated in a single segment, increasing exposure to regional risks.
  • Free cash flow is negative, indicating that capital expenditures are outpacing operating cash flow.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTRY
Revenue$259.7M
Gross profit$54.6M
Operating income$45.0M
Net income-$25.1M
R&D
SG&A
D&A
SBC
Operating cash flow$133.3M
CapEx-$8.2M
Free cash flow-$27.7M
Total assets$707.1M
Total liabilities$319.1M
Total equity$387.9M
Cash & equivalents$3.9M
Long-term debt$234.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$163.7M$9.2M$2.5M$4.2M
FY-3$669.1M$109.2M-$7.3M-$7.0M
FY-2$790.5M$192.6M-$45.1M-$111.9M
FY-1$579.4M$130.4M-$134.1M-$175.8M
FY0$661.6M$105.2M-$161.4M-$137.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$270.6M$114.4M$37.8M
FY-3$817.0M$381.9M$31.2M
FY-2$1.02B$510.3M$21.3M
FY-1$1.28B$537.2M$47.9M
FY0$2.29B$712.4M$29.6M
PeriodOCFCapExFCFSBC
FY-4-$13.3M-$1.0M$4.2M
FY-3-$379.5M-$11.2M-$7.0M
FY-2$187.9M-$85.8M-$111.9M
FY-1$309.5M-$72.2M-$175.8M
FY0$9.4M-$6.3M-$137.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$259.7M$45.0M-$25.1M-$27.7M
FQ-6$127.2M$47.2M$947.2k-$36.6M
FQ-5$33.9M$10.1M-$31.9M-$42.8M
FQ-4$136.9M$22.9M-$76.7M-$72.4M
FQ-3$258.4M$59.6M-$1.4M$1.7M
FQ-2$108.0M$27.2M-$24.5M-$22.3M
FQ-1$160.1M$23.4M-$21.3M-$18.4M
FQ0$107.7M-$11.4M-$112.2M-$96.5M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$707.1M$387.9M$3.9M
FQ-6$751.8M$422.2M$8.9M
FQ-5$876.4M$436.3M$3.6M
FQ-4$1.28B$537.2M$47.9M
FQ-3$792.4M$450.3M$3.1M
FQ-2$872.4M$453.2M$6.3M
FQ-1$1.14B$466.1M$23.2M
FQ0$2.29B$712.4M$29.6M
PeriodOCFCapExFCFSBC
FQ-7$133.3M-$8.2M-$27.7M
FQ-6$215.9M-$50.9M-$36.6M
FQ-5$263.3M-$68.4M-$42.8M
FQ-4$309.5M-$72.2M-$72.4M
FQ-3$134.5M-$966.8k$1.7M
FQ-2$163.3M-$3.7M-$22.3M
FQ-1$69.9M-$5.6M-$18.4M
FQ0$9.4M-$6.3M-$96.5M
Valuation
Market price$4.81
Market cap$1.15B
Enterprise value$1.39B
P/E
Reported non-GAAP P/E
EV/Revenue5.3
EV/Op income30.8
EV/OCF10.4
P/B3.0
P/Tangible book3.0
Tangible book$387.9M
Net cash-$230.7M
Current ratio2.0
Debt/Equity0.6
ROA-3.5%
ROE-6.5%
Cash conversion-5.3%
CapEx/Revenue-3.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 1040 companies
MetricORCAYActivity
Op margin17.3%5.6% medp25 2.1% · p75 11.2%top quartile
Net margin-9.7%3.9% medp25 0.5% · p75 8.5%bottom quartile
Gross margin21.0%23.3% medp25 14.8% · p75 32.6%below median
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-3.1%-4.1% medp25 -8.9% · p75 -1.9%above median
Debt / equity60.0%37.6% medp25 7.2% · p75 84.5%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 06:02 UTC#8ddc5373
Market quoteclose TRY 3.92 · shares 0.24B diluted
no public URL
2026-05-04 01:49 UTC#1cdbd544
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 21:09 UTCJob: d7c52ae0